Generic Name and Formulations:
Calcitonin-salmon (rDNA origin) 200 IU/spray; nasal spray.
Various generic manufacturers
Indications for Calcitonin-salmon:
Limitations Of use:
Not shown to increase BMD in early postmenopausal women.
1 spray (200Units) in alternating nostrils daily.
Correct hypocalcemia and other disorders (eg, Vit. D deficiency) prior to initiating; monitor serum calcium during therapy. Supplement diet with calcium (1g/day) and Vit. D (400 IU/day); reevaluate periodically. Seizures. Do periodic nasal exams; discontinue if severe nasal ulceration occurs. Increased risk of malignancies. Pregnancy (Cat.C), nursing mothers: not recommended.
May antagonize lithium; adjust dose.
Rhinitis, epistaxis, other nasal symptoms, back pain, arthralgia, headache; hypersensitivity reactions, antibody formation.
Formerly known under the brand name Fortical or Miacalcin.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Adjunctive Therapies for Bipolar Disorder Show Promise, Need More Evidence
- Predicting Treatment-Emergent Mania to Tailor Pharmacotherapy in Bipolar Disorder
- Antidepressants Increase Seizure Risk in Youth and Severely Depressed
- Abnormalities of Cortical Thickness in Bipolar Disorder With Auditory Hallucinations
- Prevalence of Major Depressive Disorder Remains High In US Population
- The Way to the Head May Be Through the Gut: Probiotics for Depression
- Suicide-Screening Toolkit Can Help Identify Youths at High Risk for Suicide
- Agoraphobia: An Evolving Understanding of Definitions and Treatment
- Parental Pressure to Diet Linked With Long-term Harm in Adolescents
- Does Access to Medical Cannabis Reduce Risk for Opioid Abuse?
- Triiodothyronine in the Treatment of Bipolar Depression
- Suicide Risk After Self-Harm Among Adolescents, Young Adults
- E-Cigarettes Associated With More Harms Than Benefits at Population Level
- Safety, Efficacy of Deep Brain Stimulation for Alzheimer Disease Examined
- Many Teens Who Use Tobacco Don't Self-Identify as Users